NASDAQ:MGLN - Magellan Health Stock Price, Price Target & More

$110.20 -0.30 (-0.27 %)
(As of 04/20/2018 04:00 PM ET)
Previous Close$110.50
Today's Range$109.35 - $110.85
52-Week Range$67.20 - $112.25
Volume102,809 shs
Average Volume154,036 shs
Market Capitalization$2.73 billion
P/E Ratio19.97
Dividend YieldN/A
Beta0.5

About Magellan Health (NASDAQ:MGLN)

Magellan Health logoMagellan Health, Inc. provides healthcare management services in the United States. It operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans (EAP); and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine for health plans, care organizations, and employers. It also contracts with local, state, and federal governmental agencies to provide services to recipients under Medicaid, Medicare, and other government programs, such as behavioral health and EAP, as well as healthcare management and long term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. This segment offers pharmacy benefit management services, pharmacy benefit administration for state Medicaid and other government sponsored programs, pharmaceutical dispensing services, clinical and formulary management programs, medical pharmacy management programs, and programs for the integrated management of specialty drugs that treat complex conditions. The company provides services to health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, and third party administrators. Magellan Health, Inc. was founded in 1969 and is headquartered in Scottsdale, Arizona.

Receive MGLN News and Ratings via Email

Sign-up to receive the latest news and ratings for MGLN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryManaged Health Care
SectorMedical
SymbolNASDAQ:MGLN
CUSIP55907920
Phone602-572-6050

Debt

Debt-to-Equity Ratio0.58%
Current Ratio1.66%
Quick Ratio1.62%

Price-To-Earnings

Trailing P/E Ratio19.97
Forward P/E Ratio17.44
P/E Growth1.17

Sales & Book Value

Annual Sales$5.84 billion
Price / Sales0.46
Cash Flow$10.4952 per share
Price / Cash10.50
Book Value$53.09 per share
Price / Book2.08

Profitability

EPS (Most Recent Fiscal Year)$5.50
Net Income$110.20 million
Net Margins1.89%
Return on Equity10.86%
Return on Assets4.91%

Miscellaneous

Employees10,700
Outstanding Shares24,620,000

How to Become a New Pot Stock Millionaire

Magellan Health (NASDAQ:MGLN) Frequently Asked Questions

What is Magellan Health's stock symbol?

Magellan Health trades on the NASDAQ under the ticker symbol "MGLN."

How were Magellan Health's earnings last quarter?

Magellan Health (NASDAQ:MGLN) posted its quarterly earnings data on Tuesday, February, 27th. The company reported $2.55 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $2.29 by $0.26. The firm earned $1.69 billion during the quarter, compared to analyst estimates of $1.62 billion. Magellan Health had a return on equity of 10.86% and a net margin of 1.89%. The business's quarterly revenue was up 34.1% on a year-over-year basis. During the same period last year, the company posted $1.80 EPS. View Magellan Health's Earnings History.

When is Magellan Health's next earnings date?

Magellan Health is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Magellan Health.

What guidance has Magellan Health issued on next quarter's earnings?

Magellan Health issued an update on its FY18 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of $6.37-7.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.97. The company issued revenue guidance of $7.5-7.8 billion, compared to the consensus revenue estimate of $7.58 billion.

What price target have analysts set for MGLN?

4 analysts have issued 1 year target prices for Magellan Health's shares. Their forecasts range from $73.00 to $105.00. On average, they expect Magellan Health's stock price to reach $90.6667 in the next year. View Analyst Ratings for Magellan Health.

Who are some of Magellan Health's key competitors?

Who are Magellan Health's key executives?

Magellan Health's management team includes the folowing people:
  • Mr. Barry Morgan Smith, Chairman & CEO (Age 64)
  • Mr. Jonathan N. Rubin, Chief Financial Officer (Age 54)
  • Mr. Daniel N. Gregoire, Gen. Counsel & Sec. (Age 62)
  • Mr. Sanjeev K. Srivastava, Chief Exec. Officer of Magellan Healthcare (Age 51)
  • Mr. Mostafa M. Kamal, Chief Exec. Officer of Magellan Rx Management (Age 37)

Has Magellan Health been receiving favorable news coverage?

Headlines about MGLN stock have trended somewhat positive this week, according to Accern. Accern rates the sentiment of news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Magellan Health earned a news impact score of 0.11 on Accern's scale. They also assigned media coverage about the company an impact score of 46.87 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of Magellan Health?

Shares of MGLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Magellan Health's stock price today?

One share of MGLN stock can currently be purchased for approximately $110.20.

How big of a company is Magellan Health?

Magellan Health has a market capitalization of $2.73 billion and generates $5.84 billion in revenue each year. The company earns $110.20 million in net income (profit) each year or $5.50 on an earnings per share basis. Magellan Health employs 10,700 workers across the globe.

How can I contact Magellan Health?

Magellan Health's mailing address is 4800 SCOTTSDALE ROAD, SCOTTSDALE AZ, 85251. The company can be reached via phone at 602-572-6050 or via email at [email protected]


MarketBeat Community Rating for Magellan Health (MGLN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  218 (Vote Underperform)
Total Votes:  443
MarketBeat's community ratings are surveys of what our community members think about Magellan Health and other stocks. Vote "Outperform" if you believe MGLN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MGLN will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Magellan Health (NASDAQ:MGLN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Magellan Health in the last 12 months. Their average twelve-month price target is $90.6667, suggesting that the stock has a possible downside of 17.73%. The high price target for MGLN is $105.00 and the low price target for MGLN is $73.00. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.752.50
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $90.6667$90.6667$90.6667$81.25
Price Target Upside: 17.73% downside13.11% downside1.53% upside3.16% downside

Magellan Health (NASDAQ:MGLN) Consensus Price Target History

Price Target History for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ:MGLN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/15/2018Leerink SwannUpgradeMarket Perform -> OutperformMediumView Rating Details
12/2/2017Raymond JamesReiterated RatingHoldHighView Rating Details
12/1/2017KeyCorpSet Price TargetBuy$105.00HighView Rating Details
10/13/2017Jefferies GroupReiterated RatingBuy$94.00N/AView Rating Details
11/23/2016BarclaysBoost Price TargetUnderweight$61.00 -> $69.00N/AView Rating Details
(Data available from 4/21/2016 forward)

Earnings

Magellan Health (NASDAQ:MGLN) Earnings History and Estimates Chart

Earnings by Quarter for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ:MGLN) Earnings Estimates

Current Year EPS Consensus Estimate: $6.32 EPS
Next Year EPS Consensus Estimate: $7.33 EPS

Magellan Health (NASDAQ MGLN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2018$1.08N/AView Earnings Details
2/27/2018Q4 2017$2.29$2.55$1.6157 billion$1.6944 billionViewN/AView Earnings Details
11/1/2017Q3 2017$1.40$1.64$1.4932 billion$1.4194 billionViewN/AView Earnings Details
7/28/2017Q2 2017$0.94$0.46$1.3980 billion$1.4190 billionViewN/AView Earnings Details
4/26/2017Q1 2017$0.70$0.74$1.3333 billion$1.3056 billionViewN/AView Earnings Details
2/24/2017Q416$1.68$1.80$1.33 billion$1.26 billionViewN/AView Earnings Details
11/9/2016Q316$0.67$1.39$1.22 billion$1.29 billionViewListenView Earnings Details
7/29/2016Q216$0.62$0.58$1.15 billion$1.16 billionViewListenView Earnings Details
5/5/2016Q116$0.55$0.54$1.04 billion$1.1170 billionViewN/AView Earnings Details
2/29/2016Q415$0.83$1.39$1.23 billion$1.2687 billionViewListenView Earnings Details
10/27/2015Q315$0.49$0.53$1.19 billion$1.19 billionViewListenView Earnings Details
7/27/2015Q215$0.38$0.17$1.09 billion$1.16 billionViewListenView Earnings Details
4/30/2015Q115$0.38$0.73$1.02 billion$981.00 millionViewN/AView Earnings Details
2/26/2015Q414$0.49$1.04$980.37 million$982.50 millionViewListenView Earnings Details
10/24/2014Q314$0.44$1.09$930.10 million$823.20 millionViewListenView Earnings Details
7/25/2014Q214$0.56$0.25$863.10 million$888.00 millionViewListenView Earnings Details
4/29/2014Q114$0.75$0.92$1,000.00 million$966.50 millionViewListenView Earnings Details
3/3/2014Q413$0.83$0.67$990.55 million$1.01 millionViewN/AView Earnings Details
10/24/2013Q313$1.01$1.70$875.26 million$873.60 millionViewN/AView Earnings Details
7/25/2013Q2 2013$1.01$1.15$852.42 million$842.70 millionViewN/AView Earnings Details
4/30/2013Q1 2013$0.88$1.01$864.04 million$821.30 millionViewN/AView Earnings Details
2/28/2013Q4 2012$1.05$1.32$835.55 million$830.30 millionViewN/AView Earnings Details
10/26/2012Q312$0.96$1.12$845.16 million$798.40 millionViewN/AView Earnings Details
7/27/2012$0.91$0.97ViewN/AView Earnings Details
4/27/2012$0.90$0.75ViewN/AView Earnings Details
2/28/2012$0.77$1.05ViewN/AView Earnings Details
10/27/2011$0.84$1.03ViewN/AView Earnings Details
7/29/2011$0.86$1.07ViewN/AView Earnings Details
4/29/2011$0.79$1.02ViewN/AView Earnings Details
2/24/2011$0.91$0.95ViewN/AView Earnings Details
10/29/2010Q3 2010$0.92$1.31ViewN/AView Earnings Details
7/29/2010Q2 2010$0.73$1.05ViewN/AView Earnings Details
4/30/2010Q1 2010$0.65$0.73ViewN/AView Earnings Details
2/26/2010Q4 2009$1.04$1.25ViewN/AView Earnings Details
10/30/2009Q3 2009$0.66$0.88ViewN/AView Earnings Details
7/31/2009Q2 2009$0.53$0.53ViewN/AView Earnings Details
4/30/2009Q1 2009$0.51$0.37ViewN/AView Earnings Details
2/27/2009Q4 2008$0.55$0.61ViewN/AView Earnings Details
10/31/2008Q3 2008$0.53$0.58ViewN/AView Earnings Details
7/31/2008Q2 2008$0.47$0.54ViewN/AView Earnings Details
5/2/2008Q1 2008$0.45$0.43ViewN/AView Earnings Details
2/29/2008Q4 2007$0.65$0.78ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Magellan Health (NASDAQ:MGLN) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Magellan Health (NASDAQ MGLN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.60%
Institutional Ownership Percentage: 96.12%
Insider Trading History for Magellan Health (NASDAQ:MGLN)
Institutional Ownership by Quarter for Magellan Health (NASDAQ:MGLN)

Magellan Health (NASDAQ MGLN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/2/2018Barry M SmithCEOSell13,375$103.52$1,384,580.0057,605View SEC Filing  
3/5/2018Daniel N GregoireGeneral CounselSell22,875$99.05$2,265,768.75View SEC Filing  
3/5/2018Mostafa KamalCEOSell15,428$99.04$1,527,989.12View SEC Filing  
3/1/2018Barry M SmithCEOSell13,375$101.20$1,353,550.0042,807View SEC Filing  
2/1/2018Barry M SmithCEOSell13,375$99.20$1,326,800.0042,807View SEC Filing  
1/2/2018Barry M SmithCEOSell13,367$95.94$1,282,429.9842,799View SEC Filing  
1/2/2018Jonathan N RubinCFOSell17,443$96.07$1,675,749.0143,890View SEC Filing  
12/4/2017Clapper Caskie LewisInsiderSell59,313$93.99$5,574,828.8748,474View SEC Filing  
12/4/2017Mostafa KamalCEOSell2,180$92.00$200,560.002,180View SEC Filing  
12/1/2017Daniel N GregoireGeneral CounselSell8,275$89.08$737,137.0016,690View SEC Filing  
11/1/2017Daniel N GregoireGeneral CounselSell9,369$89.20$835,714.8022,826View SEC Filing  
11/1/2017Mostafa KamalCEOSell1,154$92.00$106,168.001,154View SEC Filing  
10/4/2017Daniel N GregoireGeneral CounselSell12,475$88.02$1,098,049.50View SEC Filing  
10/3/2017Jeffrey N WestSVPSell30,021$87.31$2,621,133.51View SEC Filing  
10/2/2017Jeffrey N WestSVPSell19,007$86.22$1,638,783.5426,962View SEC Filing  
9/29/2017Jeffrey N WestSVPSell18,511$86.18$1,595,277.9829,395View SEC Filing  
9/28/2017Jeffrey N WestSVPSell25,316$85.85$2,173,378.6029,243View SEC Filing  
9/28/2017Mostafa KamalCEOSell4,848$85.76$415,764.484,848View SEC Filing  
9/27/2017Daniel N GregoireGeneral CounselSell35,658$85.17$3,036,991.8649,115View SEC Filing  
9/27/2017Jeffrey N WestSVPSell19,921$85.30$1,699,261.3019,511View SEC Filing  
9/27/2017Mostafa KamalCEOSell19,126$85.33$1,632,021.5811,819View SEC Filing  
9/15/2017Daniel N GregoireGeneral CounselSell20,465$83.05$1,699,618.2531,520View SEC Filing  
9/15/2017Mostafa KamalCEOSell2,961$84.00$248,724.002,961View SEC Filing  
9/13/2017Daniel N GregoireGeneral CounselSell14,096$83.06$1,170,813.7627,553View SEC Filing  
9/13/2017Mostafa KamalCEOSell604$83.00$50,132.0019View SEC Filing  
9/11/2017Daniel N GregoireGeneral CounselSell2,400$83.00$199,200.0015,857View SEC Filing  
9/11/2017Mostafa KamalCEOSell670$83.00$55,610.00670View SEC Filing  
9/8/2017Mostafa KamalCEOSell6,267$81.53$510,948.516,267View SEC Filing  
9/7/2017Mostafa KamalCEOSell2,190$81.07$177,543.30157View SEC Filing  
7/25/2017Daniel N GregoireGeneral CounselSell4,559$80.68$367,820.1218,016View SEC Filing  
7/24/2017Daniel N GregoireGeneral CounselSell33,574$80.11$2,689,613.1414,633View SEC Filing  
7/20/2017Daniel N GregoireGeneral CounselSell16,073$80.06$1,286,804.3829,530View SEC Filing  
7/20/2017Jeffrey N WestSVPSell1,109$80.01$88,731.0915,040View SEC Filing  
7/17/2017Jeffrey N WestSVPSell28,514$80.07$2,283,115.9817,085View SEC Filing  
7/14/2017Daniel N GregoireGeneral CounselSell14,114$80.11$1,130,672.5427,573View SEC Filing  
2/24/2017Jeffrey N WestSVPSell13,512$80.31$1,085,148.7224,587View SEC Filing  
2/23/2017Eran BroshyDirectorSell4,867$80.00$389,360.007,960View SEC Filing  
2/3/2017Jeffrey N WestSVPSell15,055$76.46$1,151,105.3018,248View SEC Filing  
2/1/2017Jeffrey N WestSVPSell3,346$76.05$254,463.3012,903View SEC Filing  
12/8/2016Clapper Caskie LewisInsiderSell55,590$74.43$4,137,563.7033,029View SEC Filing  
12/7/2016Jonathan N RubinCFOSell42,966$73.27$3,148,118.8233,134View SEC Filing  
12/5/2016Jonathan N RubinCFOSell1,600$73.05$116,880.0021,721View SEC Filing  
12/1/2016Jonathan N RubinCFOSell1,150$73.23$84,214.5021,271View SEC Filing  
11/30/2016Jonathan N RubinCFOSell7,620$73.01$556,336.2027,741View SEC Filing  
11/29/2016Jonathan N RubinCFOSell7,177$73.01$523,992.7727,298View SEC Filing  
7/12/2016Jeffrey N WestSVPBuy267$51.99$13,881.3311,375View SEC Filing  
1/15/2016Jeffrey N WestSVPBuy105$52.41$5,503.0510,730View SEC Filing  
7/15/2015Jeffrey N WestSVPBuy298$50.22$14,965.56View SEC Filing  
3/19/2015Daniel N GregoireGeneral CounselSell26,232$68.47$1,796,105.04View SEC Filing  
3/16/2015Daniel N GregoireGeneral CounselSell15,528$66.80$1,037,270.40View SEC Filing  
3/16/2015Jonathan N RubinCFOSell21,270$66.59$1,416,369.30View SEC Filing  
3/13/2015Daniel N GregoireGeneral CounselSell9,765$66.21$646,540.65View SEC Filing  
3/2/2015Daniel N GregoireGeneral CounselSell20,365$64.48$1,313,135.20View SEC Filing  
6/30/2014Daniel N GregoireGeneral CounselSell21,675$62.25$1,349,268.75View SEC Filing  
6/26/2014Jonathan N RubinCFOSell29,700$61.92$1,839,024.00View SEC Filing  
6/25/2014Jonathan N RubinCFOSell18,400$62.40$1,148,160.00View SEC Filing  
6/24/2014Jonathan N RubinCFOSell19,200$62.46$1,199,232.00View SEC Filing  
6/23/2014Jonathan N RubinCFOSell21,700$62.73$1,361,241.00View SEC Filing  
6/20/2014Jonathan N RubinCFOSell31,200$62.99$1,965,288.00View SEC Filing  
6/19/2014Jonathan N RubinCFOSell18,600$62.73$1,166,778.00View SEC Filing  
6/18/2014Jonathan N RubinCFOSell35,896$62.79$2,253,909.84View SEC Filing  
6/17/2014Jonathan N RubinCFOSell23,996$62.22$1,493,031.12View SEC Filing  
6/16/2014Jonathan N RubinCFOSell13,041$62.18$810,889.38View SEC Filing  
6/16/2014Tina BlasiCEOSell10,775$62.07$668,804.25View SEC Filing  
6/13/2014Tina BlasiCEOSell10,247$62.03$635,621.41View SEC Filing  
5/19/2014Barry SmithCEOBuy10,000$58.56$585,600.0013,427View SEC Filing  
5/14/2014Robert LeblancDirectorBuy10,000$55.60$556,000.0029,939View SEC Filing  
3/6/2014Tina BlasiCEOSell10,527$60.42$636,041.348,353View SEC Filing  
12/20/2013Daniel GregoireGeneral CounselSell10,631$58.00$616,598.006,877View SEC Filing  
12/3/2013Rene LererChairmanSell28,321$61.01$1,727,864.2184,089View SEC Filing  
12/2/2013Rene LererChairmanSell36,000$61.30$2,206,800.0084,089View SEC Filing  
11/26/2013Rene LererChairmanSell5,055$60.75$307,091.2584,089View SEC Filing  
11/22/2013Rene LererChairmanSell14,700$60.67$891,849.0084,089View SEC Filing  
11/18/2013Rene LererChairmanSell33,215$61.34$2,037,408.1084,089View SEC Filing  
11/14/2013Rene LererDirectorSell52,541$59.99$3,151,934.5984,089View SEC Filing  
11/12/2013Rene LererChairmanSell36,500$59.34$2,165,910.0084,089View SEC Filing  
11/8/2013Rene LererChairmanSell15,200$59.62$906,224.0084,089View SEC Filing  
11/6/2013Rene LererChairmanSell96,773$59.27$5,735,735.7184,089View SEC Filing  
11/4/2013Rene LererChairmanSell62,900$59.01$3,711,729.00View SEC Filing  
10/24/2013Tina BlasiCEOSell12,331$62.00$764,522.00View SEC Filing  
7/11/2013Jonathan N RubinCFOSell24,500$57.53$1,409,485.00View SEC Filing  
7/9/2013Jonathan N RubinCFOSell27,950$57.92$1,618,864.00View SEC Filing  
7/8/2013Jonathan N RubinCFOSell6,150$57.05$350,857.50View SEC Filing  
6/19/2013Jonathan N RubinCFOSell1,600$57.06$91,296.00View SEC Filing  
6/3/2013Clapper Caskie LewisInsiderSell43,399$55.00$2,386,945.00View SEC Filing  
5/31/2013Clapper Caskie LewisInsiderSell14,002$55.00$770,110.00View SEC Filing  
10/5/2012Tina BlasiCEOSell3,000$52.06$156,180.00View SEC Filing  
10/3/2012Tina BlasiCEOSell1,955$52.03$101,718.65View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Magellan Health (NASDAQ MGLN) News Headlines

Source:
DateHeadline
Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals after Flooding in Hawai’iMagellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals after Flooding in Hawai’i
finance.yahoo.com - April 20 at 4:16 PM
Magellan Rx Management Releases New Employer Market Insights ReportMagellan Rx Management Releases New Employer Market Insights Report
finance.yahoo.com - April 19 at 9:47 AM
Zacks Investment Research Upgrades Magellan Health (MGLN) to "Buy"Zacks Investment Research Upgrades Magellan Health (MGLN) to "Buy"
www.americanbankingnews.com - April 17 at 9:49 PM
Magellan Rx Management Announces Results from Hemophilia Management Program in Honor of World Hemophilia DayMagellan Rx Management Announces Results from Hemophilia Management Program in Honor of World Hemophilia Day
finance.yahoo.com - April 17 at 10:07 AM
MEDNAX (MD) vs. Magellan Health (MGLN) Critical SurveyMEDNAX (MD) vs. Magellan Health (MGLN) Critical Survey
www.americanbankingnews.com - April 17 at 7:13 AM
Magellan Health (MGLN) Scheduled to Post Earnings on TuesdayMagellan Health (MGLN) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - April 17 at 4:12 AM
Magellan Health (MGLN) Expected to Post Quarterly Sales of $1.83 BillionMagellan Health (MGLN) Expected to Post Quarterly Sales of $1.83 Billion
www.americanbankingnews.com - April 17 at 4:02 AM
Zacks: Brokerages Anticipate Magellan Health (MGLN) to Announce $0.99 Earnings Per ShareZacks: Brokerages Anticipate Magellan Health (MGLN) to Announce $0.99 Earnings Per Share
www.americanbankingnews.com - April 15 at 9:16 AM
Magellan Health (MGLN) Lowered to Sell at BidaskClubMagellan Health (MGLN) Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 14 at 10:19 PM
Magellan Health (MGLN) Lifted to "Hold" at BidaskClubMagellan Health (MGLN) Lifted to "Hold" at BidaskClub
www.americanbankingnews.com - April 12 at 6:14 PM
Is It Time To Sell Magellan Health Inc (NASDAQ:MGLN) Based Off Its PE Ratio?Is It Time To Sell Magellan Health Inc (NASDAQ:MGLN) Based Off Its PE Ratio?
finance.yahoo.com - April 12 at 10:44 AM
Select Medical (SEM) versus Magellan Health (MGLN) Critical AnalysisSelect Medical (SEM) versus Magellan Health (MGLN) Critical Analysis
www.americanbankingnews.com - April 12 at 8:39 AM
Head-To-Head Comparison: Magellan Health (MGLN) and Select Medical (SEM)Head-To-Head Comparison: Magellan Health (MGLN) and Select Medical (SEM)
www.americanbankingnews.com - April 10 at 11:21 PM
Contrasting Select Medical (SEM) and Magellan Health (MGLN)Contrasting Select Medical (SEM) and Magellan Health (MGLN)
www.americanbankingnews.com - April 10 at 5:13 AM
Why the Earnings Streak Will Continue for Magellan Health (MGLN)Why the Earnings Streak Will Continue for Magellan Health (MGLN)
finance.yahoo.com - April 9 at 10:02 AM
Magellan Health (MGLN) Upgraded to "Strong-Buy" by ValuEngineMagellan Health (MGLN) Upgraded to "Strong-Buy" by ValuEngine
www.americanbankingnews.com - April 6 at 11:51 AM
Magellan Health (MGLN) Given Consensus Recommendation of "Buy" by BrokeragesMagellan Health (MGLN) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 5 at 1:16 PM
Insider Selling: Magellan Health (MGLN) CEO Sells 13,375 Shares of StockInsider Selling: Magellan Health (MGLN) CEO Sells 13,375 Shares of Stock
www.americanbankingnews.com - April 4 at 4:16 PM
Comparing Magellan Health (MGLN) and Select Medical (SEM)Comparing Magellan Health (MGLN) and Select Medical (SEM)
www.americanbankingnews.com - April 3 at 1:26 PM
 Brokerages Expect Magellan Health Inc (MGLN) Will Post Quarterly Sales of $1.83 Billion Brokerages Expect Magellan Health Inc (MGLN) Will Post Quarterly Sales of $1.83 Billion
www.americanbankingnews.com - March 31 at 3:04 AM
 Brokerages Anticipate Magellan Health Inc (MGLN) Will Announce Earnings of $0.99 Per Share Brokerages Anticipate Magellan Health Inc (MGLN) Will Announce Earnings of $0.99 Per Share
www.americanbankingnews.com - March 29 at 1:52 PM
Edited Transcript of MGLN earnings conference call or presentation 27-Feb-18 1:30pm GMTEdited Transcript of MGLN earnings conference call or presentation 27-Feb-18 1:30pm GMT
finance.yahoo.com - March 28 at 10:03 AM
Magellan Health to Participate at Nephron Research Pharma Pricing and Benefit Management SymposiumMagellan Health to Participate at Nephron Research Pharma Pricing and Benefit Management Symposium
finance.yahoo.com - March 28 at 10:03 AM
Financial Contrast: Quality Systems (QSII) & Magellan Health (MGLN)Financial Contrast: Quality Systems (QSII) & Magellan Health (MGLN)
www.americanbankingnews.com - March 27 at 1:12 PM
Zacks Investment Research Downgrades Magellan Health (MGLN) to HoldZacks Investment Research Downgrades Magellan Health (MGLN) to Hold
www.americanbankingnews.com - March 25 at 10:57 AM
Magellan Health (MGLN) Upgraded by Zacks Investment Research to "Buy"Magellan Health (MGLN) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - March 23 at 10:46 PM
Head to Head Survey: Magellan Health (MGLN) vs. Interpace Diagnostics Gr (IDXG)Head to Head Survey: Magellan Health (MGLN) vs. Interpace Diagnostics Gr (IDXG)
www.americanbankingnews.com - March 21 at 11:26 PM
Magellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Residents Impacted by the High School Shooting in Great Mills, MarylandMagellan Health Opens a Toll-Free Crisis Line to Provide Free Counseling and Referral Services to Residents Impacted by the High School Shooting in Great Mills, Maryland
finance.yahoo.com - March 21 at 4:07 PM
BidaskClub Upgrades Magellan Health (MGLN) to Strong-BuyBidaskClub Upgrades Magellan Health (MGLN) to Strong-Buy
www.americanbankingnews.com - March 17 at 11:32 AM
Today’s Research Reports on Trending Tickers: Magellan Health and Geron Corp.Today’s Research Reports on Trending Tickers: Magellan Health and Geron Corp.
finance.yahoo.com - March 16 at 10:09 AM
Magellan Health (MGLN) Upgraded at Leerink SwannMagellan Health (MGLN) Upgraded at Leerink Swann
www.americanbankingnews.com - March 15 at 11:42 PM
 Analysts Expect Magellan Health Inc (MGLN) Will Post Quarterly Sales of $1.81 Billion Analysts Expect Magellan Health Inc (MGLN) Will Post Quarterly Sales of $1.81 Billion
www.americanbankingnews.com - March 14 at 8:42 AM
Magellan Health to Participate in Annual Needham Healthcare ConferenceMagellan Health to Participate in Annual Needham Healthcare Conference
finance.yahoo.com - March 13 at 10:13 AM
 Analysts Anticipate Magellan Health Inc (MGLN) Will Announce Earnings of $0.95 Per Share Analysts Anticipate Magellan Health Inc (MGLN) Will Announce Earnings of $0.95 Per Share
www.americanbankingnews.com - March 12 at 9:38 AM
Magellan Health (MGLN) Rating Lowered to Buy at ValuEngineMagellan Health (MGLN) Rating Lowered to Buy at ValuEngine
www.americanbankingnews.com - March 11 at 11:42 PM
Magellan Health Inc (MGLN) Receives Consensus Rating of "Buy" from AnalystsMagellan Health Inc (MGLN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - March 11 at 4:02 PM
Magellan Expands Digital Innovation Platform and StrategyMagellan Expands Digital Innovation Platform and Strategy
finance.yahoo.com - March 9 at 5:09 PM
Insider Selling: Magellan Health Inc (MGLN) CEO Sells 15,428 Shares of StockInsider Selling: Magellan Health Inc (MGLN) CEO Sells 15,428 Shares of Stock
www.americanbankingnews.com - March 6 at 6:14 PM
Magellan Health Inc (MGLN) General Counsel Sells $2,265,768.75 in StockMagellan Health Inc (MGLN) General Counsel Sells $2,265,768.75 in Stock
www.americanbankingnews.com - March 6 at 6:14 PM
Magellan Health Inc (MGLN) Shares Bought by California Public Employees Retirement SystemMagellan Health Inc (MGLN) Shares Bought by California Public Employees Retirement System
www.americanbankingnews.com - March 6 at 5:26 AM
Magellan Health Inc (MGLN) Shares Bought by Swiss National BankMagellan Health Inc (MGLN) Shares Bought by Swiss National Bank
www.americanbankingnews.com - March 5 at 4:30 PM
Bogle Investment Management L P DE Invests $2.08 Million in Magellan Health Inc (MGLN) StockBogle Investment Management L P DE Invests $2.08 Million in Magellan Health Inc (MGLN) Stock
www.americanbankingnews.com - March 5 at 5:42 AM
Kennedy Capital Management Inc. Lowers Stake in Magellan Health Inc (MGLN)Kennedy Capital Management Inc. Lowers Stake in Magellan Health Inc (MGLN)
www.americanbankingnews.com - March 4 at 8:25 AM
Spark Investment Management LLC Sells 11,400 Shares of Magellan Health Inc (MGLN)Spark Investment Management LLC Sells 11,400 Shares of Magellan Health Inc (MGLN)
www.americanbankingnews.com - March 3 at 12:36 PM
Arrowstreet Capital Limited Partnership Purchases 28,302 Shares of Magellan Health Inc (MGLN)Arrowstreet Capital Limited Partnership Purchases 28,302 Shares of Magellan Health Inc (MGLN)
www.americanbankingnews.com - March 3 at 4:24 AM
Insider Selling: Magellan Health Inc (MGLN) CEO Sells 13,375 Shares of StockInsider Selling: Magellan Health Inc (MGLN) CEO Sells 13,375 Shares of Stock
www.americanbankingnews.com - March 2 at 12:14 PM
Magellan Health Inc (MGLN) Files 10-K for the Fiscal Year Ended on December 31, 2017Magellan Health Inc (MGLN) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - March 2 at 9:38 AM
Magellan Rx Managements Annual Medical Pharmacy Trend Report ReleasedMagellan Rx Management's Annual Medical Pharmacy Trend Report Released
finance.yahoo.com - March 1 at 4:33 PM
EAM Investors LLC Buys New Position in Magellan Health Inc (MGLN)EAM Investors LLC Buys New Position in Magellan Health Inc (MGLN)
www.americanbankingnews.com - March 1 at 12:04 PM
Wired News – Actinium Pharma Announced Activation of Sixteen Clinical Trial Sites in Phase-3 SIERRA Trial for Iomab-BWired News – Actinium Pharma Announced Activation of Sixteen Clinical Trial Sites in Phase-3 SIERRA Trial for Iomab-B
finance.yahoo.com - March 1 at 9:27 AM

SEC Filings

Magellan Health (NASDAQ:MGLN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Magellan Health (NASDAQ:MGLN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Magellan Health (NASDAQ MGLN) Stock Chart for Saturday, April, 21, 2018

Loading chart…

This page was last updated on 4/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.